Ignite Creation Date:
2024-05-06 @ 12:33 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03798743
Status:
COMPLETED
Last Update Posted:
2022-03-02
First Post:
2019-01-05
Brief Title:
Phase II Study on Sintilimab Combined With Docetaxel for Chemotherapy Failure Advanced NSCLC the SUCCESS Study
Sponsor:
Organization:
Hunan Province Tumor Hospital